FDA Nominee Dr. Heidi Overton Affirms Support for Vaccine Safety During Senate Hearing

Miami Fort Lauderdale, FL, September 24, 2026 — During a Senate confirmation hearing held in Washington D.C., Dr. Heidi Overton, nominee for the Food and Drug Administration (FDA), expressed her endorsement for the safety of established vaccines. Her testimony specifically included support for the safety of the Measles, Mumps, and Rubella (MMR) vaccine.

The hearing provided a platform for senators to question Dr. Overton on several key issues. Among the topics discussed were past initiatives undertaken during the Trump administration that aimed to alter childhood immunization schedules. Senators also pressed Dr. Overton on her commitment to upholding scientific integrity in her potential role at the FDA.

Dr. Overton’s statements on vaccine safety, particularly her affirmation regarding the MMR vaccine, were a central part of her testimony. The questioning from senators touched upon the broader context of vaccine policy and the importance of scientific evidence in public health decisions. Details regarding the specific initiatives to alter childhood immunization schedules, including their nature and the timeline of their consideration, were not extensively elaborated upon in the summary provided.

The confirmation process involves scrutiny of nominees by the Senate to assess their qualifications and stance on critical policy matters. Dr. Overton’s responses during the hearing are intended to inform the senators’ decision on her suitability for the FDA leadership position. The proceedings focused on her alignment with established public health principles and her approach to scientific governance.

Story summarized from the original created by By MATTHEW PERRONE, Associated Press on www.local10.com, see more information here.